Human Creation Holdings, Inc. Stock

Equities

7361

JP3794470009

Employment Services

Delayed Japan Exchange 08:17:13 2024-05-19 pm EDT 5-day change 1st Jan Change
2,193 JPY +1.62% Intraday chart for Human Creation Holdings, Inc. -2.53% -16.20%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 6.86B 44.01M Sales 2025 * 7.27B 46.66M Capitalization 3.56B 22.84M
Net income 2024 * 393M 2.52M Net income 2025 * 425M 2.73M EV / Sales 2024 * 0.52 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.49 x
P/E ratio 2024 *
9 x
P/E ratio 2025 *
8.32 x
Employees 815
Yield 2024 *
2.78%
Yield 2025 *
3.01%
Free-Float 65.16%
More Fundamentals * Assessed data
Dynamic Chart
Human Creation Holdings, Inc. announces an Equity Buyback for 24,000 shares, representing 1.45% for ¥48 million. CI
Human Creation Holdings, Inc. authorizes a Buyback Plan. CI
Human Creation Holdings, Inc. completed the acquisition of TARA Co., Ltd. from Shota Iwasaki, Masaya Hirano, Haruhiko Adachi and Kazutoshi Tani. CI
Human Creation Holdings, Inc. agreed to acquire TARA Co., Ltd. from Shota Iwasaki, Masaya Hirano, Haruhiko Adachi and Kazutoshi Tani. CI
Human Creation Holdings, Inc. Reports Earnings Results for the Half Year Ended March 31, 2023 CI
Human Creation Holdings, Inc.'s Equity Buyback announced on December 15, 2022, has expired. CI
Human Creation Holdings, Inc. announces an Equity Buyback for 100,000 shares, representing 5.8% for ¥300 million. CI
Human Creation Holdings, Inc. authorizes a Buyback Plan. CI
Tranche Update on Human Creation Holdings, Inc.'s Equity Buyback Plan announced on February 10, 2022. CI
Human Creation Holdings, Inc.'s Equity Buyback announced on February 10, 2022, has closed with 96,400 shares, representing 5.35% for ¥199.95 million. CI
Tranche Update on Human Creation Holdings, Inc.'s Equity Buyback Plan announced on February 10, 2022. CI
Tranche Update on Human Creation Holdings, Inc.'s Equity Buyback Plan announced on February 10, 2022. CI
Human Creation Holdings, Inc. completed the acquisition of Cosmopia Co., Ltd. from Midori Ogura and Masayoko Muto. CI
Tranche Update on Human Creation Holdings, Inc.'s Equity Buyback Plan announced on November 30, 2021. CI
Human Creation Holdings, Inc. concluded a contract to acquire Cosmopia Co., Ltd. from Midori Ogura and Masayoko Muto for ¥300 million. CI
More news
1 day+1.62%
1 week-2.53%
Current month-4.69%
1 month-3.48%
3 months-8.24%
6 months-3.01%
Current year-16.20%
More quotes
1 week
2 130.00
Extreme 2130
2 291.00
1 month
2 130.00
Extreme 2130
2 350.00
Current year
2 130.00
Extreme 2130
2 776.00
1 year
2 130.00
Extreme 2130
2 999.00
3 years
1 583.00
Extreme 1583
4 555.00
5 years
1 583.00
Extreme 1583
4 555.00
10 years
1 583.00
Extreme 1583
4 555.00
More quotes
Managers TitleAgeSince
President 53 16-10-31
Chief Administrative Officer 43 17-04-30
Director/Board Member 57 17-03-31
Members of the board TitleAgeSince
Director/Board Member 44 16-09-30
President 53 16-10-31
Director/Board Member 54 16-10-31
More insiders
Date Price Change Volume
24-05-19 2,193 +1.62% 1 600
24-05-17 2,158 +0.47% 5,800
24-05-16 2,148 -2.85% 13,100
24-05-15 2,211 -0.67% 9,100
24-05-14 2,226 -1.07% 7,100

Delayed Quote Japan Exchange, May 19, 2024 at 08:17 pm EDT

More quotes
Human Creation Holdings Inc is a Japan-based company mainly engaged in engineer dispatch business through its subsidiaries. The Company’s main business is the system solution service business. The system solution service business is an engineer dispatch business that participates in development projects such as in-house system construction for companies entrusted via major customers, and it develops and maintains systems based on the resident of engineers at client companies. In addition, the Company also builds a system directly entrusted by the end user who is the user of the system. The company is providing services for the financial services industry, manufacturing and distribution industry, energy industry, public and medical industry, as well as telecommunications and media industry.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW